Literature DB >> 25680410

Pancreatic cancer: diagnosis and treatments.

Hong-Yu Li1, Zhong-Min Cui, Jiang Chen, Xiao-Zhong Guo, Ying-Yi Li.   

Abstract

Pancreatic cancer is one of the deadliest cancers, with exceptionally high mortality. Despite the relatively low incidence rate (10th), it is the fourth leading cause of cancer-related deaths in most developed countries. To improve the early diagnosis of pancreatic cancer and strengthen the standardized comprehensive treatment are still the main focus of pancreatic cancer research. Here, we summarized the rapid developments in the diagnosis and treatments of pancreatic cancer. Regarding diagnosis, we reviewed advances in medical imaging technology, tumor markers, molecular biology (e.g., gene mutation), and proteomics. Moreover, great progress has also been made in the treatments of this disease, including surgical resection, chemotherapy, targeted radiotherapy, targeted minimally invasive treatment, and molecular targeted therapy. Therefore, we also recapitulated the development, advantages, and disadvantages of each of the treatment methods in this review.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25680410     DOI: 10.1007/s13277-015-3223-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  74 in total

1.  EUS/EUS-FNA for suspected pancreatic cancer: influence of chronic pancreatitis and clinical presentation with or without obstructive jaundice on performance characteristics.

Authors:  Naveen B Krishna; Mohit Mehra; Amith V Reddy; Banke Agarwal
Journal:  Gastrointest Endosc       Date:  2009-02-27       Impact factor: 9.427

2.  The ABCC4 gene is a promising target for pancreatic cancer therapy.

Authors:  Zhuo Zhang; Jiancheng Wang; Baiyong Shen; Chenghong Peng; Minhua Zheng
Journal:  Gene       Date:  2011-10-02       Impact factor: 3.688

Review 3.  Tissue sampling at ERCP in suspected pancreatic cancer.

Authors:  J G Lee; J Leung
Journal:  Gastrointest Endosc Clin N Am       Date:  1998-01

Review 4.  Monoclonal antibody therapies targeting pancreatic ductal adenocarcinoma.

Authors:  Kevin Engelhardt; Christopher Riley; Laurence Cooke; Daruka Mahadevan
Journal:  Curr Drug Discov Technol       Date:  2006-12

Review 5.  Treatment of resectable and locally advanced pancreatic cancer.

Authors:  B W Kuvshinoff; M P Bryer
Journal:  Cancer Control       Date:  2000 Sep-Oct       Impact factor: 3.302

6.  Outcome of paraaortic node-positive pancreatic head and bile duct adenocarcinoma.

Authors:  Takanori Yoshida; Toshifumi Matsumoto; Atsushi Sasaki; Kohei Shibata; Masanori Aramaki; Seigo Kitano
Journal:  Am J Surg       Date:  2004-06       Impact factor: 2.565

7.  3D radiotherapy can be safely combined with sandwich systemic gemcitabine chemotherapy in the management of pancreatic cancer: factors influencing outcome.

Authors:  Nigel Spry; Jennifer Harvey; Craig Macleod; Martin Borg; Samuel Y Ngan; Jeremy L Millar; Peter Graham; Yvonne Zissiadis; Andrew Kneebone; Susan Carroll; Terri Davies; William H H Reece; Barry Iacopetta; David Goldstein
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-12-31       Impact factor: 7.038

8.  Pancreatic cancer: FDG-PET is not useful in early pancreatic cancer diagnosis.

Authors:  Oliver Strobel; Markus W Büchler
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-12       Impact factor: 46.802

9.  An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer.

Authors:  Su-Hyung Hong; David E Misek; Hong Wang; Eric Puravs; Thomas J Giordano; Joel K Greenson; Dean E Brenner; Diane M Simeone; Craig D Logsdon; Samir M Hanash
Journal:  Cancer Res       Date:  2004-08-01       Impact factor: 12.701

10.  Comparison between multislice CT and MR imaging in the diagnostic evaluation of patients with pancreatic masses.

Authors:  M Fusari; S Maurea; M Imbriaco; C Mollica; G Avitabile; F Soscia; L Camera; M Salvatore
Journal:  Radiol Med       Date:  2010-01-15       Impact factor: 3.469

View more
  16 in total

1.  Ski modulate the characteristics of pancreatic cancer stem cells via regulating sonic hedgehog signaling pathway.

Authors:  Libin Song; Xiangyuan Chen; Song Gao; Chenyue Zhang; Chao Qu; Peng Wang; Luming Liu
Journal:  Tumour Biol       Date:  2016-10-12

2.  Integrin β6 acts as an unfavorable prognostic indicator and promotes cellular malignant behaviors via ERK-ETS1 pathway in pancreatic ductal adenocarcinoma (PDAC).

Authors:  Zequn Li; Pengfei Lin; Chao Gao; Cheng Peng; Song Liu; Huijie Gao; Ben Wang; Jiayong Wang; Jun Niu; Weibo Niu
Journal:  Tumour Biol       Date:  2015-11-07

3.  EGFR-targeted gelatin nanoparticles for systemic administration of gemcitabine in an orthotopic pancreatic cancer model.

Authors:  Amit Singh; Jing Xu; George Mattheolabakis; Mansoor Amiji
Journal:  Nanomedicine       Date:  2015-12-03       Impact factor: 5.307

4.  Survivin expression and serum levels in pancreatic cancer.

Authors:  He Dong; Dongmeng Qian; Yaqiu Wang; Lingsheng Meng; Dong Chen; Xiangyu Ji; Wei Feng
Journal:  World J Surg Oncol       Date:  2015-05-28       Impact factor: 2.754

Review 5.  TGF-β in pancreatic cancer initiation and progression: two sides of the same coin.

Authors:  Wei Shen; Guo-Qing Tao; Yu Zhang; Bing Cai; Jian Sun; Zhi-Qiang Tian
Journal:  Cell Biosci       Date:  2017-08-07       Impact factor: 7.133

6.  Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis.

Authors:  Xuan Zou; Jishu Wei; Zebo Huang; Xin Zhou; Zipeng Lu; Wei Zhu; Yi Miao
Journal:  Cancer Med       Date:  2019-04-21       Impact factor: 4.452

7.  Bioinformatics Analysis of a Prognostic miRNA Signature and Potential Key Genes in Pancreatic Cancer.

Authors:  Shuoling Chen; Chang Gao; Tianyang Yu; Yueyang Qu; Gary Guishan Xiao; Zunnan Huang
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244

Review 8.  The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives.

Authors:  Shun Wang; Yan Zheng; Feng Yang; Le Zhu; Xiao-Qiang Zhu; Zhe-Fang Wang; Xiao-Lin Wu; Cheng-Hui Zhou; Jia-Yan Yan; Bei-Yuan Hu; Bo Kong; De-Liang Fu; Christiane Bruns; Yue Zhao; Lun-Xiu Qin; Qiong-Zhu Dong
Journal:  Signal Transduct Target Ther       Date:  2021-07-05

Review 9.  Diet and Pancreatic Cancer Prevention.

Authors:  Ilaria Casari; Marco Falasca
Journal:  Cancers (Basel)       Date:  2015-11-23       Impact factor: 6.639

10.  Mesenchymal stem cells promote pancreatic adenocarcinoma cells invasion by transforming growth factor-β1 induced epithelial-mesenchymal transition.

Authors:  Hai-Sen Zhou; Xiao-Fang Su; Xing-Li Fu; Guo-Zhong Wu; Kun-Lun Luo; Zheng Fang; Feng Yu; Hong Liu; Hong-Juan Hu; Liu-Sheng Chen; Bing Cai; Zhi-Qiang Tian
Journal:  Oncotarget       Date:  2016-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.